Initial responsiveness to darbepoetin alfa and its contributing factors in non-dialysis chronic kidney disease patients in Japan
Terumasa Hayashi, Ichiei Narita(Niigata University), Masahiro Kamouchi(Kyushu University), Hideki Kato(Nagoya City University Hospital), Kyoichi Mizuno(Nippon Medical School), Manabu Iwasaki(Niigata University), Masaomi Nangaku(The University of Tokyo), Shoichi Maruyama(Nagoya University), Yoshiharu Tsubakihara(Graduate School of Health Care Sciences, Jikei Institute), Tatsuo Kagimura(Foundation for Biomedical Research and Innovation), Tadao Akizawa(Showa University), Enyu Imai(Takara (Japan)), Takashi Wada(FIND), Hiroyasu Yamamoto(Japanese Society for Dialysis Therapy), Takao Masaki(Hiroshima University Hospital), Yasushi Yamazaki(Kagawa Prefectural Central Hospital), Hiroki Hase(Niigata University), Kenichiro Tanabe(Niigata University), Hideki Hirakata(Japanese Society for Dialysis Therapy), Hiroshi Satō(Sendai Shakai Hoken Hospital)
Cited by 15
Related Papers
Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
|New England Journal of Medicine|2013|990
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
|The Lancet|2017|923
In Vivo Diagnosis of Plaque Erosion and Calcified Nodule in Patients With Acute Coronary Syndrome by Intravascular Optical Coherence Tomography
|Journal of the American College of Cardiology|2013|840
Abundant Tau Filaments and Nonapoptotic Neurodegeneration in Transgenic Mice Expressing Human P301S Tau Protein
|Journal of Neuroscience|2002|777